<div id="readability-page-1"><p>In a report released on February 13, Justin Keywood from Stifel Nicolaus maintained a Buy rating on Jamieson Wellness Inc, with a price target of <span id="expert-recommendation-target">C$42.00</span>. The company’s shares closed last Friday at C$37.45.</p><h3>President's Day Sale - 70% Off</h3><ul><li>Unlock  hedge fund-level data  and  powerful investing tools  for smarter, sharper decisions  </li><li> Stay ahead of the market with  the latest news and analysis  and maximize your portfolio's potential</li></ul> <p>According to TipRanks, Keywood is an analyst with an average return of <span>-4.5%</span> and a 46.23% success rate. Keywood covers the Healthcare sector, focusing on stocks such as WELL Health Technologies Corp, HLS Therapeutics Inc, and kneat.com.</p> <p>The word on The Street in general, suggests a Moderate Buy analyst consensus rating for Jamieson Wellness Inc with a C$42.00 average price target.</p></div>

JWEL

<p>Stifel Nicolaus has maintained a Buy rating for Jamieson Wellness Inc (JWEL) with a price target of C$42.00, while the shares closed at C$37.45. Analyst Justin Keywood has an average return of -4.5% and a 46.23% success rate. The overall analyst consensus for Jamieson Wellness Inc is a Moderate Buy with an average price target of C$42.00.</p>

Stifel Nicolaus Sticks to Its Buy Rating for Jamieson Wellness Inc (JWEL)